Selective extracorporeal apheresis device removing over 95% of neutrophil extracellular traps (NETs) and cell‑free DNA in a single pass using histone H1.3‑conjugated porous polymer beads. Therapeutic and diagnostic technology for critical‑care patients to reduce NET‑related pathology while preserving neutrophil defensive function.